Realcan Pharmaceutical Group Co., Ltd. (SZSE:002589) agreed to acquire 9.6409% of Shandong Lekang Jinyue Industrial Co., Ltd. from Yantai Chenghou Investment Co., Ltd for CNY 84.84 million on December 14, 2022. The consideration for this transfer shall be paid within three working days after this Agreement takes effect. The transaction was approved by Realcan Pharmaceutical Group Co., Ltd. 25th meeting of the fourth board of directors.

After the transfer is completed, Shandong Lekang Jinyue Industrial Co., Ltd. will become a wholly-owned subsidiary of the Realcan Pharmaceutical Group Co., Ltd. (SZSE:002589). For the year ended, October 31, 2022, Shandong Lekang Jinyue Industrial Co., Ltd. total asset is CNY 1191.01 million and Owners' equity is CNY 737.537 million.